StockCIK 728387
Perspective Therapeutics, Inc. (CATX): Insider Trades and Fund Holdings
In the past 12 months, Perspective Therapeutics, Inc. insiders reported 0 open-market purchases worth $0 and 7 sales worth $1.62M; 0 of the sales were reported as made under a 10b5-1 trading plan.
0Insider buys, 12 months
$0Bought by insiders, 12 months
$1.62MSold by insiders, 12 months
1Tracked funds holding
Recent insider trades
Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Sep 8, 2026.
| Filed | Insider | Type | Value |
|---|---|---|---|
| Sep 8 | Lantheus Alpha Therapy, LLC10% owner | ▼ SELL | $526K |
| Sep 8 | Lantheus Alpha Therapy, LLC10% owner | ▼ SELL | $251K |
| Sep 4 | Lantheus Alpha Therapy, LLC10% owner | ▼ SELL | $246K |
| Sep 4 | Lantheus Alpha Therapy, LLC10% owner | ▼ SELL | $131K |
| Sep 4 | Lantheus Alpha Therapy, LLC10% owner | ▼ SELL | $112K |
| Sep 3 | Lantheus Holdings, Inc.10% owner | ▼ SELL | $112K |
| Sep 2 | Lantheus Holdings, Inc.10% owner | ▼ SELL | $246K |
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings
Insiders who traded in the past year
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Lantheus Alpha Therapy, LLC | 10% owner | 0 | $0 | 5 | $1.27M |
| Lantheus Holdings, Inc. | 10% owner | 0 | $0 | 2 | $357K |
ADVERTISEMENT
320 × 100 ad slot
Tracked funds that report CATX
From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.
| Fund | Shares | Value | Change |
|---|---|---|---|
| Renaissance Technologies | 59,133 | $202K | ▲ New |
Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings
Reading these numbers
Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →